Literature DB >> 10898498

HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells.

A King1, D S Allan, M Bowen, S J Powis, S Joseph, S Verma, S E Hiby, A J McMichael, Y W Loke, V M Braud.   

Abstract

Non-classical MHC class I molecule HLA-E is the ligand for CD94/NKG2 NK cell receptors. Surface expression of HLA-E requires binding of specific HLA class I leader sequences. The uterine mucosa in early pregnancy (decidua) is infiltrated by large numbers of NK cells, which are closely associated with placental trophoblast cells. In this study we demonstrate that trophoblast cells express HLA-E on their cell surface in addition to the previously reported expression of HLA-G and HLA-C. Furthermore, we show that the vast majority of decidual NK cells bind to HLA-E tetrameric complexes and this binding is inhibited by mAb to CD94. Thus, recognition of fetal HLA-E by decidual NK cells may play a key role in regulation of placentation. The functional consequences of decidual NK cell interaction were investigated in cytotoxicity assays using polyclonal decidual NK cells. The overall effect of CD94/NKG2 interaction with HLA-E is inhibition of cytotoxicity by decidual NK cells. However, since decidual NK cells are unable to kill trophoblast even in the presence of mAb to MHC class I molecules and NK cell receptors, HLA-E interaction with CD94/NKG2 receptors may regulate other functions besides cytolysis during implantation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10898498     DOI: 10.1002/1521-4141(200006)30:6<1623::AID-IMMU1623>3.0.CO;2-M

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  83 in total

1.  The oxidoreductase ERp57 efficiently reduces partially folded in preference to fully folded MHC class I molecules.

Authors:  Antony N Antoniou; Stuart Ford; Magnus Alphey; Andrew Osborne; Tim Elliott; Simon J Powis
Journal:  EMBO J       Date:  2002-06-03       Impact factor: 11.598

Review 2.  Preeclampsia, an implantation disorder.

Authors:  Leslie L Waite; Amy K Atwood; Robert N Taylor
Journal:  Rev Endocr Metab Disord       Date:  2002-05       Impact factor: 6.514

3.  HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels.

Authors:  Thomas Vauvert F Hviid; Sine Hylenius; Christina Rørbye; Lone G Nielsen
Journal:  Immunogenetics       Date:  2003-04-24       Impact factor: 2.846

4.  Pivotal role of CEACAM1 protein in the inhibition of activated decidual lymphocyte functions.

Authors:  Gal Markel; Dana Wolf; Jacob Hanna; Roi Gazit; Debra Goldman-Wohl; Yuval Lavy; Simcha Yagel; Ofer Mandelboim
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

Review 5.  The role of NK cells in the autoimmune thyroid disease-associated pregnancy loss.

Authors:  Emiliana Konova
Journal:  Clin Rev Allergy Immunol       Date:  2010-12       Impact factor: 8.667

6.  A commentary on gestational programming and functions of HLA-G in pregnancy.

Authors:  J S Hunt; P J Morales; J L Pace; A T Fazleabas; D K Langat
Journal:  Placenta       Date:  2007-03-09       Impact factor: 3.481

7.  Non-classical MHC-E (Mamu-E) expression in the rhesus monkey placenta.

Authors:  S V Dambaeva; G I Bondarenko; R L Grendell; R H Kravitz; M Durning; T G Golos
Journal:  Placenta       Date:  2007-11-09       Impact factor: 3.481

8.  Vascular endothelial growth factor C facilitates immune tolerance and endovascular activity of human uterine NK cells at the maternal-fetal interface.

Authors:  Satyan S Kalkunte; Teddy F Mselle; Wendy E Norris; Charles R Wira; Charles L Sentman; Surendra Sharma
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

9.  Conformation of human leucocyte antigen-C molecules at the surface of human trophoblast cells.

Authors:  Richard Apps; Lucy Gardner; Sue E Hiby; Andrew M Sharkey; Ashley Moffett
Journal:  Immunology       Date:  2008-01-18       Impact factor: 7.397

Review 10.  Pathophysiology of placentation abnormalities in pregnancy-induced hypertension.

Authors:  Mitsuko Furuya; Junji Ishida; Ichiro Aoki; Akiyoshi Fukamizu
Journal:  Vasc Health Risk Manag       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.